Development of the CRIS (Collinear ResonantIonisationAbstract. The CRIS (Collinear Resonant Ionisation Spectroscopy) beam line is a new experimental set up at the ISOLDE facility at CERN. CRIS is being constructed for highresolution laser spectroscopy measurements on radioactive isotopes. These measurements can be used to extract nuclear properties of isotopes far from stability. The CRIS beam line has been under construction since 2009 and testing of its constituent parts have been performed using stable and radioactive ion beams, in preparation for its first on-line run. This paper will present the current status of the CRIS experiment and highlight results from the recent tests.
The new collinear resonant ionization spectroscopy (Cris) experiment at Isolde, Cern uses laser radiation to stepwise excite and ionize an atomic beam for the purpose of ultra-sensitive detection of rare isotopes and hyperfine structure measurements. The technique also offers the ability to purify an ion beam that is contaminated with radioactive isobars, including the ground state of an isotope from its isomer. A new program using the Cris technique to select only nuclear isomeric states for decay spectroscopy commenced last year. The isomeric ion beam is selected using a resonance within its hyperfine structure and subsequently deflected to a decay spectroscopy station. This consists of a rotating wheel implantation system for alpha and beta decay spectroscopy, and up to three high purity germanium detectors for gamma-ray detection. This paper gives an introduction to the Cris technique, the current status of the laser assisted decay spectroscopy setup and recent results from the experiment in November 2011.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.